(Q38149224)

29 August 2017

title

Biological therapies for the treatment of cutaneous wounds: phase III and launched therapies (English)

1 reference

29 August 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Dominik Duscher

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Zeshaan N Maan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

Michael T Longaker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

8

Geoffrey C Gurtner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Robert C Rennert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Victor W Wong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Michael Hu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Michael Sorkin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

5 October 2013

1 reference

Expert Opinion on Biological Therapy

29 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

1523-1541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

Wound repair and regeneration

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Human skin wounds: a major and snowballing threat to public health and the economy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Extracellular matrix biomaterials for soft tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

A comparative, long-term assessment of four soft tissue substitutes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Histologic and biomechanical evaluation of crosslinked and non-crosslinked biologic meshes in a porcine model of ventral incisional hernia repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Use of AlloDerm for coverage of radial forearm free flap donor site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

AlloDerm grafting for large wounds after Mohs micrographic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Long-term outcome of acellular dermal matrix when used for large traumatic open abdomen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Transforming growth factor‐β1 in a sterilized tissue derived from the pig small intestine submucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Acellular fetal bovine dermal matrix in the treatment of nonhealing wounds in patients with complex comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Porcine urinary bladder matrix: a retrospective study and establishment of protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The use of MatriDerm® and skin grafting in post-traumatic wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The use of Matriderm and autologous skin grafting in the treatment of diabetic ulcers: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The treatment of bone exposure in burns by using artificial dermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Use of acellular dermal replacement in reconstruction of nonhealing lower extremity wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Experience of Integra(®) in cancer reconstructive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

One-stage Integra reconstruction in head and neck defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Seven years' experience with Integra as a reconstructive tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The use of Hyalomatrix PA in the treatment of deep partial-thickness burns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Biobrane in the treatment of burn and scald injuries in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Biobrane: a retrospective analysis of outcomes at a specialist adult burns centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Treatment of partial-thickness burns: a prospective, randomized trial using Transcyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Effectiveness of Biobrane for treatment of partial-thickness burns in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

A clinical evaluation of Biobrane(®) and Suprathel(®) in acute burns and reconstructive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Biobrane versus duoderm for the treatment of intermediate thickness burns in children: a prospective, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Suprathel, a new skin substitute, in the management of partial-thickness burn wounds: results of a clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Apligraf in the treatment of neuropathic diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Advanced biological therapies for diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Experience with the use of apligraf to heal complicated surgical and nonsurgical wounds in a private practice setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Survival of Apligraf in acute human wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Treatment of venous leg ulcers with Dermagraft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Growth factors in diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The role of vascular endothelial growth factor in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Role of platelet-derived growth factor in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Mechanism of Human Dermal Fibroblast Migration Driven by Type I Collagen and Platelet-derived Growth Factor-BB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Analysis of run-in and treatment data in a wound outcomes registry: clinical impact of topical platelet-rich plasma gel on healing trajectory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Catrix: an easy-to-use collagen treatment for wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The MSC: an injury drugstore

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Human embryonic stem cells possess immune-privileged properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Mesenchymal stromal cells: a key player in 'innate tolerance'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Epidermal stem cells: an update on their potential in regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Topical administration of allogeneic mesenchymal stromal cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The role of stem cells in the treatment of diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs): potential role in healing cutaneous chronic wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Autologous transplantation of adipose-derived stem cells enhances skin graft survival and wound healing in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Protocol for the successful treatment of venous ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Protocol for the successful treatment of pressure ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Human fibroblast-derived dermal substitute: results from a treatment investigational device exemption (TIDE) study in diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.842972

10.1517/14712598.2013.842972

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24093722%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference